Clinical impacts of mesothelin expression in gastrointestinal carcinomas

doi:10.4291/wjgp.v7.i2.218

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10000)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

843

WORD

475

HTML

5385

Figures (1-2)

431

Tables (1-1)

227

Sum=7361

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1121

Download

1518

Sum=2639

May 15, 2016 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pathophysiol. May 15, 2016; 7(2): 218-222
Published online May 15, 2016. doi: 10.4291/wjgp.v7.i2.218

Full Size Figure Download Figure

Figure 1 Schematics showing the maturation of mesothelin protein. The primary product of the full-ERC/mesothelin gene is a 71-kDa precursor protein. This protein is physiologically cleaved, releasing a 31-kDa fragment, N-ERC/mesothelin, into the blood. MPF: Megakaryocyte potentiating factor; SMRP: Soluble mesothelin-related peptide; GPI: Glycosylphosphatidylinositol.

Citation: Einama T, Kawamata F, Kamachi H, Nishihara H, Homma S, Matsuzawa F, Mizukami T, Konishi Y, Tahara M, Kamiyama T, Hino O, Taketomi A, Todo S. Clinical impacts of mesothelin expression in gastrointestinal carcinomas. World J Gastrointest Pathophysiol 2016; 7(2): 218-222
URL: https://www.wjgnet.com/2150-5330/full/v7/i2/218.htm
DOI: https://dx.doi.org/10.4291/wjgp.v7.i2.218